550 related articles for article (PubMed ID: 36359789)
1. Aberrant B Cell Signaling in Autoimmune Diseases.
Corneth OBJ; Neys SFH; Hendriks RW
Cells; 2022 Oct; 11(21):. PubMed ID: 36359789
[TBL] [Abstract][Full Text] [Related]
2. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
Front Immunol; 2019; 10():95. PubMed ID: 30761150
[TBL] [Abstract][Full Text] [Related]
3. Ikaros prevents autoimmunity by controlling anergy and Toll-like receptor signaling in B cells.
Schwickert TA; Tagoh H; Schindler K; Fischer M; Jaritz M; Busslinger M
Nat Immunol; 2019 Nov; 20(11):1517-1529. PubMed ID: 31591571
[TBL] [Abstract][Full Text] [Related]
4. Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome.
Kolhatkar NS; Brahmandam A; Thouvenel CD; Becker-Herman S; Jacobs HM; Schwartz MA; Allenspach EJ; Khim S; Panigrahi AK; Luning Prak ET; Thrasher AJ; Notarangelo LD; Candotti F; Torgerson TR; Sanz I; Rawlings DJ
J Exp Med; 2015 Sep; 212(10):1663-77. PubMed ID: 26371186
[TBL] [Abstract][Full Text] [Related]
5. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation.
Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Akashi K; Tanaka Y
J Allergy Clin Immunol; 2012 Jun; 129(6):1594-601.e2. PubMed ID: 22541243
[TBL] [Abstract][Full Text] [Related]
6. B cell selection and susceptibility to autoimmunity.
Grimaldi CM; Hicks R; Diamond B
J Immunol; 2005 Feb; 174(4):1775-81. PubMed ID: 15699102
[TBL] [Abstract][Full Text] [Related]
7. B-cell receptor signaling in lymphoid malignancies and autoimmunity.
Avalos AM; Meyer-Wentrup F; Ploegh HL
Adv Immunol; 2014; 123():1-49. PubMed ID: 24840946
[TBL] [Abstract][Full Text] [Related]
8. TGFβ activated kinase 1 (TAK1) at the crossroad of B cell receptor and Toll-like receptor 9 signaling pathways in human B cells.
Szili D; Bankó Z; Tóth EA; Nagy G; Rojkovich B; Gáti T; Simon M; Hérincs Z; Sármay G
PLoS One; 2014; 9(5):e96381. PubMed ID: 24801688
[TBL] [Abstract][Full Text] [Related]
9. Could DNA-reactive B lymphocytes be activated through HIV-1 DNA-stimulation involving BCR/TLR-9 pathway to yield antibodies targeting viral DNA?
Norelli S
Med Hypotheses; 2014 Dec; 83(6):659-63. PubMed ID: 25441838
[TBL] [Abstract][Full Text] [Related]
10. Concomitant high expression of Toll-like receptor (TLR) and B-cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma.
Akhter A; Street L; Ghosh S; Burns BF; Elyamany G; Shabani-Rad MT; Stewart DA; Mansoor A
Hematol Oncol; 2017 Mar; 35(1):79-86. PubMed ID: 26354285
[TBL] [Abstract][Full Text] [Related]
11. BCR and co-receptor crosstalk facilitate the positive selection of self-reactive transitional B cells.
Metzler G; Kolhatkar NS; Rawlings DJ
Curr Opin Immunol; 2015 Dec; 37():46-53. PubMed ID: 26605835
[TBL] [Abstract][Full Text] [Related]
12. Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.
Hemon P; Renaudineau Y; Debant M; Le Goux N; Mukherjee S; Brooks W; Mignen O
Clin Rev Allergy Immunol; 2017 Oct; 53(2):141-165. PubMed ID: 28500564
[TBL] [Abstract][Full Text] [Related]
13. Altered B cell signalling in autoimmunity.
Rawlings DJ; Metzler G; Wray-Dutra M; Jackson SW
Nat Rev Immunol; 2017 Jul; 17(7):421-436. PubMed ID: 28393923
[TBL] [Abstract][Full Text] [Related]
14. Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells.
Du SW; Jacobs HM; Arkatkar T; Rawlings DJ; Jackson SW
J Immunol; 2018 Dec; 201(11):3258-3268. PubMed ID: 30373855
[TBL] [Abstract][Full Text] [Related]
15. B-lymphocyte tolerance and effector function in immunity and autoimmunity.
Khan WN; Wright JA; Kleiman E; Boucher JC; Castro I; Clark ES
Immunol Res; 2013 Dec; 57(1-3):335-53. PubMed ID: 24293007
[TBL] [Abstract][Full Text] [Related]
16. The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.
Crofford LJ; Nyhoff LE; Sheehan JH; Kendall PL
Expert Rev Clin Immunol; 2016 Jul; 12(7):763-73. PubMed ID: 26864273
[TBL] [Abstract][Full Text] [Related]
17. Role of inhibitory signaling in peripheral B cell tolerance.
Getahun A
Immunol Rev; 2022 May; 307(1):27-42. PubMed ID: 35128676
[TBL] [Abstract][Full Text] [Related]
18. How the Signaling Crosstalk of B Cell Receptor (BCR) and Co-Receptors Regulates Antibody Class Switch Recombination: A New Perspective of Checkpoints of BCR Signaling.
Chen Z; Wang JH
Front Immunol; 2021; 12():663443. PubMed ID: 33841447
[TBL] [Abstract][Full Text] [Related]
19. Activation of the MEK-ERK Pathway Is Necessary but Not Sufficient for Breaking Central B Cell Tolerance.
Greaves SA; Peterson JN; Torres RM; Pelanda R
Front Immunol; 2018; 9():707. PubMed ID: 29686680
[TBL] [Abstract][Full Text] [Related]
20. Signaling mechanisms regulating B-lymphocyte activation and tolerance.
Hobeika E; Nielsen PJ; Medgyesi D
J Mol Med (Berl); 2015 Feb; 93(2):143-58. PubMed ID: 25627575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
